A wider part, a thinner ponytail or more hair in the shower can feel unsettling. Midlife timing alone cannot tell us the cause. You do not need to diagnose yourself before asking for help.
What feels different?
Hair thinning becomes more common around midlife. Female-pattern hair loss often occurs with normal hormone levels, and several causes of hair change can overlap.
A pattern to understand.
A gradually widening part or thinning across the top can occur with female-pattern hair loss. A scalp assessment helps distinguish this from shedding, breakage and other conditions. A normal hormone result does not rule it out.
Choose a topic to explore, not a diagnosis. Nothing is submitted or saved.
Telogen effluvium can cause more widespread shedding a few months after illness, surgery, significant stress, weight loss or another bodily change. It can occur alongside female-pattern loss.
AAD · Female-pattern hair loss ↗British Association of Dermatologists · Telogen effluvium ↗First, put the story together.
When did it begin? Has it been gradual or sudden? Bring recent illnesses, medications, dietary or weight changes, menstrual changes and scalp discomfort into the conversation. How it is affecting you matters, too.
What changed?
The timeline and context can help the clinician decide what to look for.
Look closely.
Thinning, shedding, breakage and inflammation do not all need the same approach.
Make it fit.
The findings guide useful tests, options or a dermatology referral.
A clinician can review your history and examine your hair and scalp. A dermatologist can help distinguish different causes. A blood panel alone cannot establish every cause of hair loss.
Sudden or patchy loss, persistent scalp pain or burning, redness, scaling, sores, or a receding hairline with eyebrow loss should be evaluated. Some inflammatory conditions can cause permanent loss, so early recognition matters.
A useful test answers a question.
Selected blood tests may help investigate possibilities such as iron deficiency or thyroid disease when the history and examination suggest them. Hormone testing may be appropriate when an endocrine condition is suspected.
There is no universal “hair-loss hormone panel.” More testing does not automatically mean a clearer explanation. Ask what a test could tell you and how the result would change your care.
For otherwise healthy people aged 45 or older with typical menopause symptoms, menopause is generally assessed clinically rather than through routine hormone tests. Younger age or an atypical presentation may call for a different approach. That does not replace assessment of a separate hair concern.
Do not start iron, hormones or a collection of supplements just because hair is changing. Discuss whether there is a deficiency, another explanation or a reason to avoid a product.
British Association of Dermatologists · Evaluation of shedding ↗UCLH NHS · Understanding menopause and testing ↗Looking for testosterone, DHT and hair? Start here →
Make room for the rest of you.
Changes in periods, hot flashes, night sweats, sleep, mood or vaginal comfort may be worth a separate menopause-health conversation. Those symptoms deserve attention in their own right.
Menopausal hormone therapy can help appropriate patients with menopause symptoms after an individualized benefits-and-risks discussion. It should not be presented as an established treatment for hair loss.
Hair options should follow the hair diagnosis. Some shedding improves as its trigger resolves. Female-pattern loss and scalp inflammation may need different approaches. Topical minoxidil is an established option for female-pattern loss, but its suitability still depends on the individual.
Explore nonsurgical hair options →NHS · Perimenopause and menopause symptoms ↗The Menopause Society · Hormone therapy ↗AAD · Female-pattern hair loss treatment ↗Interesting biology.
Specific questions.
Peptides and exosomes are different biological categories. Understanding how a molecule or vesicle works does not establish that a particular product safely regrows hair.
Peptides
A peptide is a short chain of amino acids. Some peptide medicines have approved uses, but the word alone says nothing about a product’s indication or evidence. FDA has identified potential safety concerns and limited human safety information for certain compounded peptides, including injectable GHK-Cu. Compounded drugs are not FDA-approved.
Exosomes
Exosomes are small cell-derived vesicles that can carry biological material. FDA states that there are no FDA-approved exosome products. They should not be presented as routine, proven hair-restoration care.
The questions to ask
Which exact product and route? What human evidence supports this use? What is known about risks, quality and long-term effects? What is its regulatory status? “Investigational” does not itself mean it is part of an authorized trial.
This page does not offer or recommend a peptide or exosome treatment. Current availability of any specific product must be confirmed separately.
Look closer at the evidence →FDA · Certain compounded substances and safety concerns ↗FDA · Consumer alert on regenerative medicine products and exosomes ↗A connection, when it helps.
Where Vitality could fit
Advanced’s public Vitality information describes care for women and men and identifies Donna Abdelnour, APRN, FNP-C, ACNP-BC as a Vitality provider. If menopause-related concerns are part of your story, ask whether a separate assessment would help. Her role and credentials here follow the practice’s published description.
The clinician, appointment format, fees, testing and any treatment should be confirmed with the practice. A conversation about hair does not commit you to testing, prescribing or a wellness program.
Explore Vitality at Advanced ↗You can also begin with the hair question and discuss whether another clinician should be involved. You do not have to decide the cause or buy a broader program first.
Book a hair consultation ↗This is Advanced’s hair-consultation scheduler, not a verified Vitality appointment link. The consultation format should be confirmed with the practice.
The next inside story.
Felix can make the biology easier to picture. Here is a direction for a future teaching sequence, separate from any treatment claim.
Concept storyboard · Not a new finished animation
Everyone has
a schedule.
Angie, Cal and Telly introduce growth, transition and rest. Shedding is a distinct part of the story.
Different changes.
Different stories.
Contrast gradually finer hairs with increased shedding after a trigger, without assuming one hormonal cause.
Zoom out.
Then look closer.
History, scalp findings and relevant symptoms guide the conversation. Tests appear only when indicated.
A future research segment could explain peptide structure or exosome cargo. It should keep that biology separate from an unproven treatment effect.
Meet the existing hair-cycle crew →Bring the questions.
Leave the self-diagnosis.
- What patterns do you see, and could more than one cause be involved?
- Which parts of my history or scalp examination support that explanation?
- Would a test answer a useful question? What would it change?
- Should my other symptoms be assessed separately, and by whom?
- Which options have evidence for my diagnosis, and what are their limitations?
- What should we track, and when should I check back?
Sources and further reading.
Sources consulted November 8, 2026. This information is not a clinical protocol, diagnosis or promise that a specific service is available.
- American Academy of Dermatology · Female-pattern hair loss
- Healthdirect · Female-pattern hair loss and hormones
- British Association of Dermatologists · Telogen effluvium
- AAD · Diagnosis and treatment
- UCLH NHS · Understanding menopause
- The Menopause Society · Hormone therapy
- NHGRI · Peptide and NCI · Exosome
- FDA · Understanding compounded-drug risks
- Advanced · Vitality division, practice description only